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Abstract
Metastasis comprises several subsequent steps including local invasion and intravasation at the primary site, then
their adhesion/arrest within the vessels of host organs followed by their extravasation and infiltration into the
target organ stroma. In contrast to previous studies which have used aspartate–glycine–arginine (RGD) peptides
and antibodies against integrins, we used rare collagen- and laminin-antagonizing integrin inhibitors from snake
venoms to analyze the colonization of the liver by tumor cells both by intravital microscopy and in vitro. Adhesion
of liver-targeting tumor cells to the sinusoid wall components, laminin-1 and fibronectin, is essential for liver me-
tastasis. This step is inhibited by lebein-1, but not by lebein-2 or rhodocetin. Both lebeins from the Vipera lebetina
venom block integrin interactions with laminins in an RGD-independent manner. Rhodocetin is an antagonist of
α2β1 integrin, a collagen receptor on many tumor cells. Subsequent to tumor cell arrest, extravasation into the liver
stroma and micrometastasis are efficiently delayed by rhodocetin. This underlines the importance of α2β1 integrin
interaction with the reticular collagen I–rich fibers in liver stroma. Antagonists of laminin- and collagen-binding in-
tegrins could be valuable tools to individually block the direct interactions of tumor cells with distinct matrix com-
ponents of the Disse space, thereby reducing liver metastasis.
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Introduction
The liver is a common target organ for metastasizing gastrointestinal
carcinomas; moreover, hepatocellular carcinoma can spread within
the liver hematogenously. In a series of subsequent steps, the tumor
cells disseminate from their primary sites into the circulation. They
are usually transported by the blood into the liver, where they attach
to the sinusoid walls, penetrate the Disse space, and eventually mi-
grate into the liver stroma [1–3]. The sinusoidal microvessels are
characterized by discontinuous endothelial cell lining, thereby leaving
the underlying extracellular matrix (ECM) components directly acces-
sible to circulating cells [4]. Therefore, the initial arrest of blood-borne
tumor cells at liver sinusoids is not only limited to cell–cell interactions
between tumor and endothelial cells, but may also be mediated by a
direct interplay of tumor cells with ECM components of the Disse
space [5]. The ultrastructural organisation of this ECM also seems
to differ from subendothelial basement membranes in capillaries of
other organs [6].
Tumor cell attachment to, migration along and invasion through
the ECM requires cell–matrix interactions, which are predominantly
mediated by integrins [7,8]. Twenty-four different members belong
to the integrin family; all of which consist of two subunits α and β
Abbreviations: ECM, extracellular matrix; MEM, minimal essential medium; MFI, mean
fluorescence intensity; MMP, matrix metalloprotease; RGD, aspartate–glycine–arginine;
SEM, scanning electron microscopy; vWF, von Willebrand factor
Address all correspondence to: Johannes A. Eble, Institute for Physiological Chemistry,
Muenster University Hospital, Waldeyerstr. 15, 48149 Muenster, Germany.
E-mail: eble@uni-muenster.de
1This work was financially supported by the Wilhelm Sander-Stiftung (grant
2003.136.1) and the Deutsche Forschungsgemeinschaft (grant SFB492/B3) to J. A. E.,
by the Wilhelm Sander-Stiftung (grant 2004.129.1) to J. H., and by the Dr. Mildred
Scheel Stiftung (Deutsche Krebshilfe; grant 10-2041-Br1) to G. B.
Received 5 October 2007; Revised 3 December 2007; Accepted 3 December 2007
Copyright © 2008 Neoplasia Press, Inc. All rights reserved 1522-8002/08/$25.00
DOI 10.1593/neo.07898
www.neoplasia.com
Volume 10 Number 2 February 2008 pp. 168–176 168
(reviewed by Hynes [9]). The integrins α1β1, α2β1, α10β1, and α11β1
bind to the different members of the collagen superfamily [10,11].
The laminin-binding integrins differ in their specificity toward differ-
ent laminin isoforms. Whereas α3β1 integrin preferentially binds to
laminin-5 and -10, the integrins α6β1 and α6β4 recognize most lam-
inin isoforms [12–14]. Other integrins, such as α5β1 or αvβ3, bind
to an aspartate–glycine–arginine (RGD)–containing loop within their
cognate ligands, e.g., fibronectin, vitronectin, or von Willebrand factor
(vWF) [15,16]. The potential functions of these RGD-dependent in-
tegrins in cancer have already been addressed by using various snake
venom–derived RGD-containing disintegrins [17]. However, RGD-
independent integrin inhibitors from snake venoms have only recently
been identified. Rhodocetin, a C-type lectin from the Malayan pit vi-
per (Calloselasma rhodostoma), specifically inhibits α2β1 integrin
[18,19]. The two disintegrins from the Vipera lebetina venom, lebein-1
and -2, block integrin interactions with their respective laminin iso-
forms in an RGD-independent manner [20]. Additionally, lebein-1
contains an RGD sequence explaining its inhibitory potential of
cell–fibronectin interactions.
Driven by their strong potential to inhibit liver micrometastasis of
hematogenic tumor cells, we have studied the effects of rhodocetin
and the lebeins on adhesion, migration, and infiltration of a liver-
targeting tumor cell lines, such as the hepatocellular carcinoma cell
line HepG2 and the colorectal carcinoma cell line HT29LMM, both
in vitro and in vivo.
Materials and Methods
Cells, Antibodies, and Integrin Antagonists
HepG2 cells were grown in minimal essential medium (MEM), con-
taining 20% FCS (BioWest, Nuaille, France), and HT29LMM were
cultured in RPMI 1640 containing 10% FCS, both under standard
conditions. The following antibodies against integrin subunits were
used for FACS analysis: AGF1 against α1 (H. Gardner, Biogen, Cam-
bridge, MA), JA218 against α2 (D. Tuckwell, F2G, Eccles, England,
UK), A3X8 against α3 (F. Berditchevski, University of Birmingham,
England, UK), VC5 against α5 (Chemicon, Hampshire, UK), GoH3
against α6 (A. Sonnenberg, The Netherlands Cancer Institute, Amster-
dam, The Netherlands), antibody Ab-1 against αv (Calbiochem, Darm-
stadt, Germany), mAb 13 against β1 (BD Biosciences, Bedford, MA),
and MAB2059 against β4 and P1F6 against β5 (both from Chemicon).
Rhodocetin and the lebeins were isolated from the crude snake venoms
as described previously [18,20].
Intravital Fluorescence Video Microscopy
Male Sprague-Dawley rats (200–250 g; Charles River, Sulzfeld,
Germany) were prepared as previously described [5,21,22]. The left
liver lobe was placed in a fixed position on its left side under an up-
right epifluorescence microscope (Zeiss, Oberkochen, Germany)
without disturbing the hepatic circulation. Images (magnification,
×20) were recorded with a video system (Peiper, Düsseldorf, Ger-
many) in real time [23]. For intravital observations, suspensions
of 1 × 106 tumor cells, which had been fluorescently labeled for
45 minutes with 1 μg/ml Calcein AM (Molecular Probes, Leiden,
The Netherlands), were injected intracardially over 60 sec. Before in-
jection, tumor cells were reconstituted in serum-free medium (RPMI
1640 containing 1% BSA) for 45 minutes. During this reconstitu-
tion period, tumor cells were incubated with the integrin inhibitors.
As previously reported [5], the injection of tumor cells and the intra-
vital microscopic technique did not interfere with cardiocirculatory
or pulmonary functions of the animals. Using a standardized proce-
dure [5,21,22,24], average numbers of adherent and extravasated
cells of 30 microscopic fields were determined in 5-minute intervals
over a 30-minute period. The relative migration rate was calculated
as percentage of migrated cells in relation to the sum of adherent and
migrated cells.
FACS Analysis of Integrin Expression
Cells were suspended in PBS containing 1% BSA (Roth, Karlsruhe,
Germany) and 1% horse serum for 1 hour. A total of 5 × 105 cells were
incubated with integrin antibody (5 μg/ml) for 75 minutes on ice. After
washing with PBS, cells were stained with the Alexa Fluor-488–labeled
secondary antibodies, and after three subsequent washing steps, were
analyzed in a flow cytometer (EPICS-XL; Coulter-Beckman, Krefeld,
Germany). The mean fluorescence intensity (MFI) of cytometric histo-
grams was normalized to the species-matched isotype controls (mouse
or rat).
Immunostaining of Liver Sections
Sections from cryopreserved liver tissue were prepared and fixed
on glass slides. After washing and blocking with 1% BSA in PBS,
specimens were incubated with the following antibodies against
matrix components: murine anti–human collagen IV mAb CIV22
(B. Odermatt, Zurich University Hospital, Switzerland), rabbit anti–
human fibronectin antiserum (D. Seidler, Muenster University Hospi-
tal, Germany), rabbit anti–human vWF antibody (Dako, Hamburg,
Germany), rabbit antibodies against type I collagen and laminin-1
(both from Acris, Hiddenhausen, Germany), diluted in 1% BSA in
PBS. After intense washing, sections were stained with the relevant
secondary antibodies conjugated with either Alexa Fluor-488 or Alexa
Fluor-568 (Invitrogen, Karlsruhe, Germany). After another washing
step, they were embedded in phosphate-buffered glycerol–Mowiol
4-88 (Sigma, Deisenhofen, Germany) containing 1% bicyclo (2,2,2)-
1,4-diazaoctane (Sigma). Confocal images were acquired as single-
channel micrographs using Nikon PCM2000 confocal laser scanning
microscope based on a Nikon Eclipse E600 and PlanApo 60×/
1.40 NA oil immersion objective (Nikon, Düsseldorf, Germany)
and were overlaid using MetaMorph software (Universal Imaging
Corporation, Puchheim, Germany).
In Vitro Inhibition Assay of Cell Attachment
Microtiter plates (Nunc, Roskilde, Denmark) were coated with
collagen I, collagen IV (BD Biosciences), fibronectin (Invitrogen),
each at 5 μg/ml, or laminin-1 at 10 μg/ml (provided by Rupert
Timpl, Max-Planck-Institut für Biochemie, Martinsried, Germany).
After blocking the wells with 1% BSA, 0.3 × 104 cells in adhesion
medium (MEM containing 1% BSA) were added to the inhibitor-
containing wells at 37°C for 15 minutes. After fixation with 4%
paraformaldehyde, cell adhesion was quantified by crystal violet
staining [25].
Scanning Electron Microscopy
Pieces of silicon wafers were coated with collagen I or laminin-1 at
10 μg/ml overnight. After blocking with 0.1% heat-denatured BSA
in PBS, HepG2 cells (50 × 103/ml) in 0.1% BSA-containing MEM
were seeded in the absence or presence of integrin inhibitors. After
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45 minutes, adherent cells were fixed with 1% glutaraldehyde for
30 minutes and washed with water. Specimens were dehydrated with
increasing ethanol concentrations, dried under vacuum and covered
with layers of platinum (2 nm) and carbon by electro sputting. Scan-
ning electron microscopy pictures were taken with the LEO 1530
VP (Zeiss) under a tilt angle of 60° at a voltage of 5 kV and in the
secondary electron mode.
Directional Cell Migration Assay in a Transwell
Migration Assay
The top and bottom face of the 8-μm-pore polycarbonate mem-
branes of Transwell chambers (Nunc) were coated with collagen I,
collagen IV, or fibronectin (each at 10 μg/ml) for 2 hours and
blocked with 1% BSA. Cells were seeded in serum-free medium
on the upper side of the membrane at 40 × 103/ml. In case of che-
motactic migration, 10% FCS was added to the lower reservoir. After
30 minutes of adhesion, cell media were supplemented with 1 nM
lebein-1, 500 nM lebein-2, or 300 nM rhodocetin. After 12 hours of
incubation at 37°C, cells on the top face of the filter were mechan-
ically removed. Migrated cells on the bottom face of the filters were
fixed in ice-cold methanol, then gently washed with 1% BSA in PBS
and stained with hematoxylin. Cell migration was assessed as the
average number of cells/field of 16 microscopic fields.
In Vitro Cell Invasion Assay through Three-Dimensional Gels
Cell invasion in vitro was determined using a double-filter assay
[26]. Briefly, thin gels consisting of type I collagen, a fibrin–casein
mixture, or matrigel basement membrane extract (BD Biosciences)
were prepared between two filters, a bottom 5-μm-pore nitrocellulose
filter (Schleicher & Schuell, Dassel, Germany) and a top 12-μm-pore
casein-coated polycarbonate filter (Reichert, Heidelberg, Germany). A
total of 1 × 105 cells in 0.5 ml of culture medium were seeded on
top of the filter sandwiches for 3 (fibrin–casein and matrigel filters)
or 20 hours (collagen filters) at 37°C. The filters were fixed overnight
at 4°C in 2.5% glutaraldehyde in PBS and were separated. The nuclei
of the cells were stained with Hoechst stain (2.5 μg/ml in PBS) for
45 minutes. Cells attached to the top filters or present in the gels
on the bottom filters were counted under a fluorescence microscope.
Cell invasion was expressed as the ratio of the cell number on the bot-
tom filter and the total number of cells present on both filters. Cell
adhesion was expressed as the ratio of the total number of cells on both
filters and the number of cells plated (1 × 105 cells).
Detection of Matrix Metalloproteases
Active matrix metalloprotease-1 (MMP-1) was detected using the
Fluorokine E, Human active MMP-1 Fluorescent assay, according
to the manufacturer’s instructions (R&D Systems, Wiesbaden, Ger-
many). The plasmalemma-anchored MMP-14 (MT1–MMP) was
quantified by flow cytometry using a mAb against MMP-14 (Sigma).
Statistical Analysis
Statistical analyses were performed with SPSS statistical program
(SPSS Inc., Chicago, IL). Data are shown as means ± SD. Groups
differing in treatment parameters were compared using the Scheffé
test (ANOVA posthoc test) for dependent or independent samples
as appropriate. For other analyses, Student’s t test was used. Signifi-
cant differences were accepted for P < .05.
Results
Rhodocetin and Lebeins Inhibit Different Steps of Liver
Colonization in an In Vivo Micrometastasis Assay
Colorectal carcinoma cells, such as HT29LMM, and hepatocellular
carcinoma cells, such as HepG2 cells, disseminate hematogenously and
colonize the liver. Having chosen these two tumor cell lines as repre-
sentative model cancer cells, we analyzed in detail the antimetastatic
effects of snake venom integrin inhibitors on liver metastasis in vivo.
After injection into the blood circulation, the tumor cells freely circu-
lated through the liver sinusoid. Within 2 minutes after injection, the
first tumor cells were observed by intravital microscopy to stick to the
sinusoid wall without rolling (Figure 1). Some adherent cells lost their
adhesive bonds after several seconds and recirculated again. Mechanical
entrapment of tumor cells was also ruled out by the fact, that calibers
of sinusoids surpassed the tumor cell diameter, as indicated by a re-
maining vessel lumen and a persistent blood flow. From their initial
intravasal arrest (Figure 2, A and C ), few adherent cells rapidly invaded
the liver stroma (Figure 1). Infiltrated HT29LMM and HepG2 cells
were detected almost immediately and as early as 5 to 10 minutes,
respectively, after cell injection (Figure 2, B and D). After 30 minutes,
approximately 20% of both tumor cells that had attached to the vessel
wall were found in the liver stroma (Figure 2, B and D, control).
Figure 1. Intravital fluorescence pictures of fluorescently labeled
HepG2 cells in the liver. The liver hepatocytes are arranged in tra-
beculae and are visible due to their autofluorescence. Fluores-
cently labeled HepG2 cells stain brightly. They are attached to
the sinusoid wall with a residual lumen still visible (A; open arrows)
or already extravasated into the liver trabeculae without any con-
tact with the sinusoid (B; filled arrows).
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When HepG2 and HT29LMM cells were treated with 350 nM
lebein-1 before injection, their attachment to the sinusoid wall was
significantly reduced (Figure 2, A and C ). In addition, lebein-1 in-
hibited extravasation of HepG2 (Figure 2B), but not of HT29LMM
cells (Figure 2D). Whereas lebein-2 did not significantly interfere
with cell arrest (Figure 2A), it remarkably reduced cell extravasation
(Figure 2B). Rhodocetin at a concentration of 160 nM did not affect
HepG2 cell arrest (Figure 2A, triangles up), but decreased tumor cell
extravasation into the liver stroma strongly (Figure 2B). Similarly,
rhodocetin had little effect on HT29LMM cell arrest but inhibited
their extravasation (Figure 2, C and D). Although less pronounced,
the extravasation-blocking effect of rhodocetin was also achieved,
when rhodocetin was injected into the blood shortly before the
HepG2 cells (Figure 2B, triangles down). These data emphasize the
role of laminin- and collagen-binding integrins in different steps of
the metastatic cascade, viz. the attachment of tumor cells to the liver
sinusoidal wall and the subsequent extravasation.
The Integrin Repertoire of HepG2 and HT29LMM Cells
HepG2 cells were characterized for their integrin receptors by flow
cytometry (Table 1). Among the collagen-binding integrins, α1β1 was
more abundantly expressed than α2β1. The most abundant laminin-
binding integrin on HepG2 was α3β1, a specific receptor for laminin-5
and -10 [13]. The more sparsely expressed integrins α6β1 and α6β4
bind to almost all laminin isoforms. Among the RGD-dependent in-
tegrins, the fibronectin-binding α5β1 integrin ranked lower in expres-
sion than αv-containing integrins. An antibody specific for αvβ3
integrin did not yield a significant signal, suggesting that the αv sub-
unit predominantly combined with integrin β subunits other than β3,
such as the β1, β5, or β6 subunit. As opposed to the HepG2 cells,
Figure 2. In vivo effects of snake venom inhibitors on the attachment of HepG2 (A, B) and HT29LMM (C, D) cells to the sinusoid wall (A,
C) and their infiltration into the liver stroma (B, D) in a rat liver metastasis model. Fluorescently labeled HepG2 or HT29LMM cells were
preincubated without any inhibitor (controls, closed circles), with lebein-1 (quadrangles), lebein-2 (diamonds), or rhodocetin (triangles up)
and injected intra-arterially. Alternatively, rhodocetin was injected shortly before the HepG2 cells (triangles down). The lebeins and rho-
docetin were applied at the final doses of approximately 350 and 160 nM, respectively. Adhesion of tumor cells to the sinusoid vessel
walls and their extravasation into the liver stroma were monitored in vivo using intravital fluorescence microscopy. From the pictures
taken from 30 microscopic fields of the rat liver within 5-minute intervals, the number of cells that have adhered to the vessel wall (A, C)
or have migrated into the liver stroma (B, D) was determined. The number of extravasated cells normalized to the number of adherent
and infiltrated cells represents the relative migration rate. For each condition, at least five rats were analyzed. Mean values and SD are
shown. In A, adhesion rates of cells treated with lebein-1 were significantly reduced at all time points (P < .01). In B, every type of
pretreatment with integrin inhibitor decreased relative migration rates significantly for observation periods of more than 5 minutes
(P < .05, or even P < .005 for later time points). In D, a significant reduction of extravasation (P < .05) was observed for rhodocetin
at 20 minutes.
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HT29LMM express comparatively more α2β1 than α1β1 integrin,
which may explain their higher responsiveness to the α2β1 integrin-
specific rhodocetin in vessel wall adhesion in the in vivo metastasis
assay. The integrin α6 subunit as part of the integrins α6β1 and
α6β4 is abundantly expressed on HT29LMM cells. The fibronectin-
binding integrins, α5β1- and αv-containing integrins, are only found
in comparatively low expression in HT29LMM cells.
The ECM of the Disse Space
Acting as integrin ligands, ECM molecules are located in the Disse
space and are directly accessible through the discontinuous endothe-
lial cell lining. Hence, the ECM influences the metastatic settlement
of tumor cells in the liver. Collagen IV, a typical basement membrane
component, colocalized with vWF, a marker for the subendothelial
ECM (Figure 3A). The von Willebrand factor is also stored in plate-
lets, which were intensely stained especially as microthrombotic ag-
gregates within the sinusoid (Figure 3A). Other basement membrane
markers, such as the laminin chains α1, β1, and γ2, were stained with
an antiserum raised against laminin-1. They also colocalized with col-
lagen IV (Figure 3B). Using antibodies against the laminin γ2 and
α5 chains, we demonstrated that neither laminin-5 (laminin-332) nor
laminin-10/11/15 (laminin-511, -521, and -523), both ligands for α3β1
integrin, were found along the sinusoidal walls (data not shown). In
addition to its collagen IV–like distribution, fibronectin irradiated
as bundles from the subendothelial ECM toward the hepatocytes (Fig-
ure 3C ). As opposed to collagen IV, collagen I was predominantly lo-
calized outside of the subendothelial ECM and was abundantly found
in bundles, which reach from the Disse space far into the hepatocyte
trabeculae (Figure 3D).
In Vitro Inhibition of Tumor Cell Attachment
The snake venom components interfered with the integrin-mediated
interactions of tumor cells with the perisinusoidal ECM and inhibited
tumor cell arrest and/or extravasation in vivo. To study the anti-
metastatic effects on these two processes separately in vitro, we first
challenged HepG2 cell adhesion to different ECM proteins by the ad-
dition of the snake venom integrin inhibitors. As shown in Figure 4A,
lebein-1 efficiently and completely blocked cell attachment to both
Table 1. Mean Fluorescence Intensity (MFI) of HepG2 and HT29LMM Cells Stained with Mono-
clonal Antibodies Directed against Different Integrin Subunits and Measured By Flow Cytometry.
HepG2 HT29LMM
α1 47.98 ± 4.79 4.57 ± 0.15
α2 14.51 ± 2.32 9.09 ± 1.15
α3 44.24 ± 5.77 11.03 ± 0.13
α6 12.39 ± 1.75 25.94 ± 3.18
α5 17.35 ± 3.28 1.43 ± 1.10
αv 38.59 ± 3.16 11.22 ± 0.23
β1 93.83 ± 3.16 21.20 ± 2.49
β4 6.38 ± 1.77 13.59 ± 0.95
β5 8.10 ± 0.68 3.43 ± 1.40
Mean fluorescence intensity values were normalized to species-matched isotype controls. The in-
tegrin α subunits, α1, α2, α3, and α5, exclusively associate with the β1 subunit, whereas the α6
subunit can combine with both β1 and β4 subunit, and the αv subunit forms heterodimers with
various β subunits, such as β5.
Figure 3. Extracellular matrix proteins surrounding the liver sinusoids. Human liver sections were stained with the monoclonal antibody
CIV22 against collagen IV (green fluorescence in A–D). Collagen IV is a typical basement membrane protein found in the Disse space
between the hepatocyte trabeculae (marked with H) and the sinusoids (marked with S) which are lined by a thin layer of endothelial cells.
von Willebrand factor as a subendothelial marker (A), laminin-1 chains, α1, β1, and γ1 (B), as well as fibronectin (C), and collagen I (D) are
detected immunohistochemically with red fluorescence (A–D). Whereas vWF (A) and laminin-1 (B) colocalize with collagen IV in a clearly
defined subendothelial zone (yellow), fibronectin (C) and especially collagen I (D) form bundles that reach out from the subendothelial
zone into the liver stroma.
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laminin-1 and fibronectin in a dose-dependent manner. Lebein-1 con-
tains RGD sequences in both its subunits, which are able to inhibit the
RGD-dependent fibronectin receptor α5β1. Although lebein-2 does
not comprise any RGD sequence, it inhibited cell attachment to fibro-
nectin and laminin-1 (Figure 4B). In comparison, lebein-1 was about
50-fold more potent than lebein-2. At higher doses, lebein-1 showed a
remarkable inhibition of HepG2 cell adhesion to collagens, although
neither of the lebeins showed a specific, divalent cation-dependent
interaction with the collagen-binding integrins, α1β1 and α2β1, in pre-
vious studies [20]. Up to a concentration of 1 μM, lebein-2 did not
affect collagen binding. Rhodocetin did not prevent HepG2 cell at-
tachment to collagens (Figure 4C ), presumably because integrin
α1β1 compensated for the specific rhodocetin blockage of α2β1 integ-
rin. It also did not affect cell attachment to laminin-1 and fibronectin.
Similarly, the attachment of HT29LMM cells to both collagen I
and collagen IV was not disturbed by rhodocetin. Despite their abun-
dance of laminin-binding α6 integrins, HT29LMM cells did not ad-
here to laminin-1. In addition, their adhesion to fibronectin was rather
poor even in the absence of the snake venom integrin inhibitors.
Lebein-1 and -2 Suppress HepG2 Cell Spreading
on Laminin-1
The laminin-1 chains were exclusively detected in the subendothe-
lial ECM. The laminins may therefore play a role in the attachment
of blood-borne HepG2 cells to the vessel wall. We scrutinized this
interaction on a single cell level in SEM (Figure 5). Cells firmly at-
tached and spread on laminin-1 and collagen I (Figure 5, A and B)
but not on BSA (Figure 5C ). As opposed to the polarized appearance
of the cells migrating on collagen I (Figure 5B), cells on laminin-1
spread and flattened thoroughly without any preferential orientation
(Figure 5A). Increasing concentrations of lebein-1 (Figure 5D) and
lebein-2 (Figure 5E ) caused loss of cell–ECM contacts and eventually
resulted in detachment. Consistently with the inhibition of cell
adhesion (Figure 4), lebein-1 was more potent than lebein-2. The
morphologic changes of the cells from a well-spread to a roundish
appearance were paralleled by a cytoskeletal reorganization, as actin
stress fibers, which span through the entire cell body, disappeared
with increasing concentrations of lebeins, whereas the cortical actin
meshwork remained intact (data not shown).
Integrin Inhibitors Suppress Migration of HepG2
Cells In Vitro
Extravasation requires tumor cell migration into the liver stroma.
This was measured in Transwell migration chambers, the filters of which
were coated with different ECM proteins. In this two-dimensional (2D)
migration assay, HepG2 cells did not migrate on laminin-1. Therefore,
only migration on collagen I, collagen IV, and fibronectin was scruti-
nized either without (Figure 6A) or with (Figure 6B) a haptotactic se-
rum gradient. In general, the presence of serum strongly increased cell
migration (Figure 6, B vs A). Both collagen I and IV supported cell mo-
tility stronger than fibronectin. Lebein-1 and lebein-2 significantly re-
duced cell movement on collagens I and IV, and completely abolished it
on fibronectin (Figure 6). The α2β1 integrin antagonist, rhodocetin, in-
hibited tumor cell movement on collagen I only, an effect which was
less pronounced in the presence of the serum gradient. Neither on col-
lagen IV, the preferential substrate for α1β1 integrin, nor on fibronectin
tumor cell motility was significantly affected by rhodocetin (Figure 6).
HT29LMM cells migrated on collagens only poorly. In addition to their
weak adhesion to laminin-1 and fibronectin, this fact excluded them
from in vitro migration studies.
In Vitro Invasion Assays through Three-Dimensional Gels
Tumor cell invasion was assessed in a double-filter assay with 3D-
ECM-gels made of collagen I, fibrin, or of the basement membrane
extract, matrigel. In contrast to the 2D Transwell migration assay,
HepG2 cells did not invade into the 3D collagen gels (Figure 7A),
presumably because they did not produce the collagen-degrading col-
lagenases, MMP-1 (Figure 8A). Obviously, their production of MMP-
14 (Figure 8B) could not compensate for this lack of soluble MMP-1.
HT29LMM cells possessed only minor amounts of MMP-14, but
strongly secreted MMP-1 (Figure 8). Nevertheless, like HepG2, they
are unable to infiltrate into the collagen gel (Figure 7). Infiltration of
Figure 4. Snake venom integrin antagonists inhibit HepG2 cell adhesion. Microtiter plates were coated with collagen I, collagen IV,
fibronectin (each at 5 μg/ml), or laminin-1 (at 10 μg/ml). Cells were allowed to adhere in the presence of lebein-1 (A), lebein-2 (B), or
rhodocetin (C). Adherent cells were stained with crystal violet and quantified photometrically. Adhesion signals were normalized to
the controls measured without inhibitors. Values and SD of duplicates are representative of several independent experiments.
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HT29LMM cells could only be detected into the matrigel (Figure 7B),
whereas HepG2 cells rapidly invaded into both the fibrin gel and the
matrigel (Figure 7A). Either lebein-1 or -2 was included into the gels in
comparatively high concentrations to compensate for diffusion losses
but were omitted from the culture medium to avoid inhibition of cell
attachment to the top filters. Nevertheless, the two lebeins reduced ini-
tial HepG2 cell adhesion to the top filter by 20% to 50% (Figure 7C ).
Adherent cells invaded the underlying matrigel or fibrin gel but were
blocked by lebein-1 drastically by up to 84% in a dose-dependent man-
ner with a stronger inhibition of invasion into fibrin gel than into ma-
trigel (Figure 7C ). Lebein-2 did not have significant effects on cell
invasion up to a concentration of even 3 μM (Figure 7C, right panel ).
Discussion
In this study, we show the applicability of the snake venom inhib-
itors, lebein-1 and -2 as well as rhodocetin, to reduce metastasis in
the liver in vivo. In contrast to the crude venom, the purified inhib-
itors did not show any adverse side effects in our in vivo experiments.
In the future, they may help to develop antimetastatic therapeutics.
To analyze the inhibition of liver metastasis also mechanistically,
we compared in vivo and in vitro experiments in which the effects
of the integrin inhibitors on cell arrest/adhesion and extravasation/
migration were tested. The in vivo data were obtained by intravital
fluorescence microscopy, a method that had been used by some
groups [27–29]. These groups either investigated the interaction
of tumor cells with endothelial cells [27,29] and/or used RGD-
dependent disintegrins or function-blocking antibodies against integ-
rins (reviewed in the study of Eble and Haier [17]). Only lebein-1
contains RGD sequences. However, its capacity to inhibit integrin
binding to laminin is entirely RGD-independent [20]. Lebein-2
and rhodocetin antagonize integrin binding to laminins and col-
lagens, respectively, also in an RGD-independent manner [18,20]. Ad-
ditionally, previous studies [30–33], including our own [5,21,24,34],
have used monoclonal antibodies to unravel the roles of different in-
tegrins in metastasis. However, being bivalent agents, antibodies
may cluster integrins and thus may act agonistically, although they pre-
vent integrin binding to the ECM ligand. Both lebeins and rhodocetin
act antagonistically. Our studies indicate that not only the RGD-
dependent integrins, such as the αvβ3 integrin [29], but also the
collagen-binding and laminin-binding integrins play pivotal roles in
the different steps of the metastatic cascade.
To colonize distant organs hematogenously, tumor cells attach to
the capillary wall. Previously, cell adhesion molecules on the surface
of endothelial cells have been pinpointed to be responsible for tumor
Figure 5. Spreading of HepG2 cells plated on laminin-1 (A), colla-
gen I (B), and BSA (C), and their dose-dependent inhibition by
lebein-1 (D) and lebein-2 (E). Silicon pieces were coated with
laminin-1 (A, D, and E) or collagen I (B), and blocked with BSA
(C). A total of 5 × 104 cells in MEM containing 0.1% BSA were
added either in the absence of integrin inhibitors (A–C) or in the
presence of either lebein-1 (D) or lebein-2 (E) at the indicated con-
centrations. After 45 minutes, cells were prepared for scanning
electron microscopy. Pictures were taken at a tilt angle of 60°.
Figure 6. Integrin inhibitors influence haptotactic cell migration on
collagen- or fibronectin-coated filters both in the absence (A) or
presence (B) of a chemotactic gradient. The Transwell filters were
coated with collagen and fibronectin, and the migration assay was
performed both in the absence (A) and in the presence (B) of 10%
FCS in the bottom compartment. The snake venom inhibitors were
added to the culture media in both the top and bottom compart-
ments: lebein-1, 1 nM; lebein-2, 500 nM; and rhodocetin, 300 nM.
A representative experiment with averages and SD of cell num-
bers determined in quadruplicate is shown. Lebein-1 and -2 signif-
icantly inhibited cell migration (P < .001), whereas rhodocetin
solely reduced cell movement on collagen I (P < .05).
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cell–endothelial cell interactions [35]. In this study, we demonstrate
that tumor cell arrest in liver sinusoids also depends on cell attachment
to the subendothelial ECM, which is accessible through the dis-
continuous endothelium. Tumor cell attachment to the liver sinusoid
wall, the first step of metastasis, was effectively inhibited by lebein-1,
which in vitro inhibited cell attachment to laminin-1, fibronectin and,
at higher concentrations, to collagen I and IV. Although the existence
of laminin in the Disse space has long been questioned [36], and the
laminin α1 and α4 chains were the only laminin α chains to be ob-
served merely during organogenesis and regeneration after hepatectomy,
along with a complete absence of laminin β1 and γ1 chains [37], we
could detect at least one of the laminin chains, α1, β1, and γ1, in the
subendothelial ECM sheet. It also contains fibronectin, which also
serves as an adhesion substrate for tumor cells in a lebein-1–inhibitable
manner. Collagen IV is recognized by the integrins α1β1 and α2β1. Be-
cause the integrin α2β1 is specifically blocked by rhodocetin without
any reduction of tumor cell arrest in vivo, we can exclude a major con-
tribution of α2β1 integrin in tumor cell attachment to the collagen
IV–rich subendothelial ECM.
Subsequent to attachment, tumor cells extravasate the blood vessel
by migrating through or along ECM components. HepG2 and
HT29LMM cells did not migrate on laminin-1 in vitro, ruling out
that laminin receptors play a major role in liver stroma infiltration.
The extravasation-blocking effect of the two lebeins in vivo must
therefore be explained by its potential to interfere with tumor cell
contacts with fibronectin that is consistent with previous studies
[30]. Bundles of fibronectin reach out from the subendothelial sheet
into the liver trabeculae and serve as substrate for tumor cell extravasa-
tion into the liver stroma. Most remarkable is the invasion-blocking
effect of rhodocetin in vivo. Being specifically directed against the
α2β1 integrin, our data pinpoint this integrin and its ligand, collagen
I, as one of the major players in liver metastasis. This explains the
previous observation that liver metastasis express α2β1 integrin in sig-
nificantly higher amounts compared to tumor cells from the primary
node [38]. HepG2 cells did not express major amounts of the colla-
genase MMP-1, whereas HT29LMM lacked the collagen-degrading
MMP-14. This could be one reason why they failed to infiltrate the
collagen gels in vitro, which constituted a comparatively dense mesh-
work of collagen fibrils. As opposed to the in vitro system, the retic-
ular collagen fibers in the liver stroma seemed to be less dense, thus
waiving the requirement for liver stroma-invading tumor cells to pro-
duce major amounts of both collagen-degrading proteases, MMP-1
and MMP-14. Whereas the integrin α1β1–mediated tumor cell arrest
to collagen IV of the subendothelial ECM was not affected by rhodo-
cetin, extravasation and invasion of tumor cells into the liver stroma
along the loosely spaced collagen fibers within the Disse space de-
pended on α2β1 integrin and hence was effectively inhibited by rho-
docetin. This is in contrast to data of Yang et al. [31] who proposed
similar functions for both collagen-binding integrins, α1β1 and α2β1.
Although we focused on HepG2 cells as a liver-targeting tumor cell
line, similar results were obtained with the colorectal tumor cells
HT29LMM, indicating that our observations are of general impor-
tance for liver metastasis.
Taken together, we showed that in addition to contacts between
tumor cells and endothelium, direct interactions of tumor cells with
the ECM of the Disse space play a key role in liver metastasis, con-
sistent with previous observations [30,39–41]. Furthermore, not
only RGD-dependent integrins can influence this process. Different
Figure 7. HepG2 (A) and HT29LMM (B) cell invasion cells into 3D
gels. Invasion of HepG2 cells into fibrin gels and matrigel is inhib-
ited by lebein-1 but not lebein-2 (C). (A) Cellular invasiveness into
matrigels, gels of fibrin–casein, or of collagen I was tested in a dou-
ble filter assay. Whereas almost a third of the cells invaded into
fibrin gels or matrigels, hardly any cells migrated through the colla-
gen gels. Mean values ± SEM of several filters are shown (matrigel,
n = 14; fibrin, n = 24; collagen, n = 11). (B) Similarly, infiltration of
HT29LMM was measured (n = 9). (C) HepG2 cell adhesion to the
top filter and infiltration into the underlying matrigel or fibrin gel
were determined in the presence of increasing concentrations of
lebein-1 (left panel) or at a high concentration of lebein-2 (3 μM, right
panel). Cellular invasiveness into fibrin gels or matrigels was signif-
icantly inhibited by lebein-1 in a dose-dependent manner (n = 14),
whereas even high concentrations of lebein-2 did not affect cell in-
vasion (n = 6).
Figure 8. Production of collagen-degrading MMPs, MMP-1 (A) and
MMP-14 (B) by HepG2, by HT29LMM, and by the positive control
fibrosarcoma cell line HT1080. (A) Active MMP-1 in the cell superna-
tants of tumor cells was quantified with a commercial ELISA. The
values were normalized to the cell numbers. (B) Membrane-bound
MMP-14 were detected with flow cytometry. The MFI signals nor-
malized to the signals of the isotype-matched control are shown.
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sets of integrins are players in tumor cell arrest and subsequent ex-
travasation. Both steps of the metastatic cascade can be inhibited in-
dividually by the integrin inhibitors, lebein-1 and rhodocetin. The
effective blockage of tumor cell invasion by the α2β1 integrin-specific
inhibitor rhodocetin emphasizes the role of this integrin and the re-
ticular collagen fibers. We hypothesize that the particular arrange-
ment of ECM in the Disse space accounts for the preference of
certain tumor cells to settle in the liver tissue. This might be one
mechanistic explanation for the observation that tumor cells targeting
the liver are rich in α2β1 integrin [38] and might lead to a novel
therapeutic strategy to reduce liver metastasis.
References
[1] Bogenrieder T and Herlyn M (2003). Axis of evil: molecular mechanisms of
cancer metastasis. Oncogene 22, 6524–6536.
[2] Fidler IJ (2003). The pathogenesis of cancer metastasis: the “seed” and “soil”
hypothesis revisited. Nat Rev Cancer 3, 1–6.
[3] Nicolson GL (1988). Cancer metastasis: tumor cell and host properties important
in colonization of specific secondary sites. Biochim Biophys Acta 948, 175–224.
[4] Hahn E, Wick G, Pencev D, and Timpl R (1980). Distribution of basement
membrane proteins in normal and fibrotic human liver: collagen type IV, laminin,
and fibronectin. Gut 21, 63–71.
[5] Haier J, Korb T, Hotz B, Spiegel HU, and Senninger N (2003). An intravital
model to monitor steps of metastatic tumor cell adhesion within the hepatic
microcirculation. J Gastrointest Surg 7, 507–515.
[6] Roos E, Dingemans KP, Van de Pavert IV, and Van den Bergh-Weerman MA
(1978). Mammary-carcinoma cells in mouse liver: infiltration of liver tissue and
interaction with Kuppfer cells. Br J Cancer 38, 88–99.
[7] Brakebusch C, Bouvard D, Stanchi F, Sakai T, and Fässler R (2002). Integrins in
invasive growth. J Clin Invest 109, 999–1006.
[8] Hood JD and Cheresh DA (2002). Role of integrins in cell invasion and migra-
tion. Nat Rev Cancer 2, 91–100.
[9] Hynes RO (2002). Integrins: bidirectional, allosteric signaling machines. Cell
110, 673–687.
[10] Eble JA (2005). Collagen-binding integrins as pharmaceutical targets. Curr
Pharm Des 11, 867–880.
[11] Myllyharju J and Kivirikko K (2004). Collagens, modifying enzymes and their
mutations in humans, flies and worms. Trends Genet 20, 33–43.
[12] Nishiuchi R, Takagi J, Hayashi M, Ido H, Yagi Y, Sanzen N, Tsuji T, Yamada
M, and Sekiguchi K (2006). Ligand-binding specificities of laminin-binding in-
tegrins: a comprehensive survey of laminin–integrin interactions using recombi-
nant α3β1, α6β1, α7β1 and α6β4 integrins. Matrix Biol 25, 189–197.
[13] Eble JA, Wucherpfennig KW, Gauthier L, Dersch P, Krukonis E, Isberg RR, and
Hemler ME (1998). Recombinant soluble human α3β1 integrin: purification,
regulation, and specific binding to laminin-5 and invasin in a mutually exclusive
manner. Biochemistry 37, 10945–10955.
[14] Colognato H and Yurchenco PD (2000). Form and function: the laminin family
of heterotrimers. Dev Dyn 218, 213–234.
[15] Ruoslahti E (1996). RGD and other recognition sequences for integrins. Annu
Rev Cell Dev Biol 12, 697–715.
[16] Eble JA (2001). The molecular basis of integrin–extracellular matrix interac-
tions. Osteoarthr Cartil 9, S131–S140.
[17] Eble JA and Haier J (2006). Integrins in cancer treatment. Curr Cancer Drug
Targets 6, 89–105.
[18] Eble JA, Beermann B, Hinz H-J, and Schmidt-Hederich A (2001). α2β1 integ-
rin is not recognized by rhodocetin but is the specific high affinity target of
rhodocetin, an RGD-independent disintegrin and potent inhibitor of cell adhe-
sion to collagen. J Biol Chem 276, 12274–12284.
[19] Eble JA and Tuckwell DS (2003). The α2β1 integrin inhibitor rhodocetin binds
to the A-domain of the integrin α2 subunit proximal to the collagen binding
site. Biochem J 376, 77–85.
[20] Eble JE, Bruckner P, and Mayer U (2003). Vipera lebetina venom contains
two disintegrins inhibiting laminin-binding β1 integrins. J Biol Chem 278,
26488–26496.
[21] Enns A, Gassmann P, Korb T, Schlüter K, Spiegel HU, Senninger N, and Haier
J (2004). Integrins can directly mediate metastatic tumor cell adhesion within
liver sinusoids. J Gastrointest Surg 8, 1049–1059.
[22] von Sengbusch A, Gassmann P, Fisch K, Nicolson GL, and Haier J (2005). Focal
adhesion kinase regulates dynamic adhesion of carcinoma cells to collagens. Am J
Pathol 166, 585–596.
[23] Uhlmann S, Uhlmann D, and Spiegel HU (1999). Evaluation of hepatic micro-
circulation by in vivo microscopy. J Invest Surg 12, 179–193.
[24] Korb T, Schlüter K, Enns A, Spiegel HU, Senninger N, Nicolson GL, and Haier
J (2004). Integrity of actin fibres and microtubules influences metastatic tumor
cell adhesion. Exp Cell Res 299, 236–247.
[25] Aumailley M, Mann K, von der Mark H, and Timpl R (1989). Cell attachment
properties of collagen type VI and Arg-Gly-Asp dependent binding to its α2(VI)
and α3(VI) chains. Exp Cell Res 181, 463–474.
[26] Erkell LJ and Schirrmacher V (1988). Quantitative in vitro assay for tumor cell in-
vasion through extracellular matrix or into protein gels. Cancer Res 48, 6933–6937.
[27] Scherbarth S and Orr FW (1997). Intravital videomicroscopic evidence for reg-
ulation of metastasis by the hepatic microvasculature: effects of interleukin-1α
on metastasis and the location of B16F1 melanoma cell arrest. Cancer Res 57,
4105–4110.
[28] Groom AC, MacDonald IC, Schmidt EE, Morris VL, and Chambers AF
(1999). Tumour metastasis to the liver, and the roles of proteinases and adhe-
sion molecules: new concepts from in vivo videomicroscopy. Can J Gastroenterol
13, 733–743.
[29] Kikkawa H, Kaihou M, Horaguchi N, Uchida T, Imafuku H, Takiguchi A,
Yamazaki Y, Koike C, Kuruto R, Kakiuchi T, et al. (2002). Role of integrin
αvβ3 in the early phase of liver metastasis: PET and IVM analyses. Clin Exp
Metastasis 19, 717–725.
[30] Tian B, Li Y, Ji X-N, Chen J, Xue Q, Ye S-L, Liu Y-K, and Tang Z-Y (2005).
Basement membrane proteins play an active role in the invasive process of human
hepatocellular carcinoma cells with high metastasis potential. J Cancer Res Clin
Oncol 131, 80–86.
[31] Yang C, Zeisberg M, Lively JC, Nyberg P, Afdhal N, and Kalluri R (2003).
Integrin α1β1 and α2β1 are the key regulators of hepatocarcinoma cell invasion
across the fibrotic matrix microenvironment. Cancer Res 63, 8312–8317.
[32] Giannelli G, Fransvea E, Marinosci F, Bergamini C, Colucci S, Schiraldi O, and
Antonaci S (2002). Transforming growth factor–β1 triggers hepatocellular car-
cinoma invasiveness via α3β1 integrin. Am J Pathol 161, 183–193.
[33] Torimura T, Ueno T, Kin M, Harada R, Nakamura T, Kawaguchi T, Harada M,
Kumashiro R, Watanabe H, Avraham R, et al. (2001). Autocrine motility factor
enhances hepatoma cell invasion across basement membrane through activation
of β1 integrins. Hepatology 34, 62–71.
[34] Enns A, Korb T, Schlüter K, Spiegel HU, Senninger N, Mitjans F, and Haier J
(2005). αvβ5 integrin mediates early steps of metastasis formation. Eur J Cancer
41, 1065–1072.
[35] Gulubova MV (2002). Expression of cell adhesion molecules, their ligands and
tumor necrosis factor a in the liver of patients with metastatic gastrointestinal
carcinomas. Histochem J 34, 67–77.
[36] Martinez-Hernandez A and Amenta PS (1995). The extracellular matrix in he-
patic regeneration. FASEB J 9, 1401–1410.
[37] Kikkawa Y, Mochizuki Y, Miner J, and Mitaka T (2005). Transient expression
of laminin α1 chain in regenerating murine liver: restricted localization of lami-
nin chains and nidogen-1. Exp Cell Res 305, 99–109.
[38] Ura H, Denno R, Hirata K, Yamaguchi K, and Yasoshima T (1998). Separate
functions of α2β1 and α3β1 integrins in the metastatic process of human gastric
carcinoma. Surg Today 28, 1001–1006.
[39] Kemperman H, Wijnands YM, and Roos E (1997). αv integrins on HT-29
colon carcinoma cells: adhesion to fibronectin is mediated solely by small amounts
of αvβ6, and αvβ5 is codistributed with actin fibers. Exp Cell Res 234, 156–164.
[40] Haier J, Nasralla M, and Nicolson GL (1999). Different adhesion properties of
highly and poorly metastatic HT-29 colon carcinoma cells with extracellular ma-
trix components: role of integrin expression and cytoskeletal components. Br J
Cancer 80, 1867–1874.
[41] Kemperman H, Wijnands YM, Meijne AML, and Roos E (1994). TA3/St, but
not TA3/Ha, mammary carcinoma cell adhesion to hepatocytes is mediated
by alpha 5 beta 1 interacting with surface-associated fibronectin. Cell Adhes
Commun 2, 45–58.
176 Antimetastatic Integrin Inhibitors of Snake Venoms Rosenow et al. Neoplasia Vol. 10, No. 2, 2008
